Please login to the form below

Not currently logged in
Email:
Password:

Eisenmenger syndrome

This page shows the latest Eisenmenger syndrome news and features for those working in and with pharma, biotech and healthcare.

Actelion reports late-stage trial failure as J&J talks continue

Actelion reports late-stage trial failure as J&J talks continue

Actelion has revealed that a late-stage trial of Opsumit in patients with Eisenmenger syndrome failed to meet its objectives, just as it is immersed in takeover talks with Johnson &Johnson ... MAESTRO involved 266 patients with pulmonary artery

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics